Gene · 25913
Papers2,597
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,597
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transformed Plasmablastic Lymphoma Presenting With Marked Lymphocytosis and Spontaneous Tumor Lysis Syndrome. | J Hematol | 2023 | 36895289 | PubTator, text mining | PubMed |
| Recent advancements in the structural biology of human telomerase and their implications for improved design of cancer therapeutics. | NAR Cancer | 2023 | 36879683 | PubTator, text mining | PubMed |
| Association of germline variants in telomere maintenance genes (POT1, TERF2IP, ACD, and TERT) with spitzoid morphology in familial melanoma: A multi-center case series. | JAAD Int | 2023 | 36876055 | PubTator, text mining | PubMed |
| Characterization of clonal immunoglobulin heavy V-D-J gene rearrangements in Chinese patients with chronic lymphocytic leukemia: Clinical features and molecular profiles. | Front Oncol | 2023 | 36874132 | PubTator, text mining | PubMed |
| Present and future perspectives in early diagnosis and monitoring for progressive fibrosing interstitial lung diseases. | Front Med (Lausanne) | 2023 | 36873896 | PubTator, text mining | PubMed |
| The interplay between telomeric complex members and BCR::ABL1 oncogenic tyrosine kinase in the maintenance of telomere length in chronic myeloid leukemia. | J Cancer Res Clin Oncol | 2023 | 36871092 | PubTator, text mining | PubMed |
| Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception. | Breast Cancer Res Treat | 2023 | 36856935 | PubTator, text mining | PubMed |
| Automated SSHHPS Analysis Predicts a Potential Host Protein Target Common to Several Neuroinvasive (+)ssRNA Viruses. | Viruses | 2023 | 36851756 | PubTator, text mining | PubMed |
| In-depth circulating tumor DNA sequencing for prognostication and monitoring in natural killer/T-cell lymphomas. | Front Oncol | 2023 | 36845680 | PubTator, text mining | PubMed |
| Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of upper urinary tract and urinary bladder. | World J Surg Oncol | 2023 | 36841776 | PubTator, text mining | PubMed |
| Telomere Length as a New Risk Marker of Early-Onset Colorectal Cancer. | Int J Mol Sci | 2023 | 36834938 | PubTator, text mining | PubMed |
| Hereditary Cancer Syndrome in a Family with Double Mutation in BRIP1 and MUTYH Genes. | Genes (Basel) | 2023 | 36833355 | PubTator, text mining | PubMed |
| Telomere Fragility and MiDAS: Managing the Gaps at the End of the Road. | Genes (Basel) | 2023 | 36833275 | PubTator, text mining | PubMed |
| Aging, Physical Exercise, Telomeres, and Sarcopenia: A Narrative Review. | Biomedicines | 2023 | 36831134 | PubTator, text mining | PubMed |
| Exploring Genetic Interactions with Telomere Protection Gene pot1 in Fission Yeast. | Biomolecules | 2023 | 36830739 | PubTator, text mining | PubMed |
| Sirtuins and redox signaling interplay in neurogenesis, neurodegenerative diseases, and neural cell reprogramming. | Front Neurosci | 2023 | 36816109 | PubTator, text mining | PubMed |
| Cell Immortalization: In Vivo Molecular Bases and In Vitro Techniques for Obtention. | BioTech (Basel) | 2023 | 36810441 | PubTator, text mining | PubMed |
| Distinct genome-wide DNA methylation and gene expression signatures in classical monocytes from African American patients with systemic sclerosis. | Clin Epigenetics | 2023 | 36803404 | PubTator, text mining | PubMed |
| Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma. | Haematologica | 2023 | 36794502 | PubTator, text mining | PubMed |
| Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesothelioma. | Cell Rep Med | 2023 | 36773602 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25913/papers?page=18